Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy.

Morinaga, Soichiro

Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy. [electronic resource] - Anticancer research Mar 2016 - 1083-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1791-7530


Aged
Carcinoma, Pancreatic Ductal--drug therapy
Chemotherapy, Adjuvant
Deoxycytidine--administration & dosage
Drug Resistance, Neoplasm
Female
Humans
In Situ Hybridization
Male
MicroRNAs--genetics
Middle Aged
Oligonucleotides--genetics
Pancreatic Neoplasms--drug therapy
Prognosis
Survival Analysis
Treatment Outcome
Gemcitabine